Smart Seha

smartseha.com

Smart Seha is a telehealth service company that provides members access to healthcare via phone or internet. This reduces the need to go to a clinic or hospital in non-urgent cases, and allows you to seek medical advice wherever you are. We currently offer 3 services: Call a Doctor, Ask a Doctor and Second Medical Opinion. For more information please visit www.smartseha.com

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

TASLY PHARMACEUTICALS AND MAUNA KEA TECHNOLOGIES ANNOUNCE JOINT VENTURE AND LICENSING AGREEMENTS

Mauna Kea Technologies | July 12, 2022

news image

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, and Tasly Pharmaceuticals announced the execution of an agreement to form a Joint Venture. Under terms of the agreement, Tasly and Mauna Kea will form a Joint Venture that will (i) commercialize selected Cellvizio indications in China, (ii) develop and commercialize Cellvizio globally in the fields of Neurology and Neurosurgery, and (iii) manufact...

Read More

Business Insights

OPTIMIZERX ACQUIRES EVINCEMED, A SPECIALTY DRUG PRESCRIPTION INITIATION PLATFORM

OptimizeRx Corporation | March 16, 2022

news image

OptimizeRx Corp. a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a leader in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform supporting pharma manufacturers, hub providers and pharmacies to improve patient access, speed to therapy and activation of af...

Read More

Business Insights, PHARMACY MARKET

VERISTAT ACQUIRES EUROPEAN MEDICAL WRITING CONSULTANCY SCINOPSIS

Businesswire | June 13, 2023

news image

Veristat, a scientific-minded global clinical research organization (CRO), has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory and medical communication documents of the highest quality to the biopharmaceutical industry. The acquisition strengthens Veristat’s ability to meet growing client demand in one of its highest-valued service areas as the range of clinical trial content expands and the importance of regulatory doc...

Read More

Pharma Tech

CPHI PARTNERS WITH INFORMA PHARMA INTELLIGENCE TO PRESENT THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO IN THE NATIONAL CAPITAL REGION ( NCR)

Informa Pharma Intelligence | November 26, 2021

news image

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, is pleased to announce the 2021 hybrid edition of CPhI – P-MEC conducted by CPhI Conference. The Online Conference & Networking is being held between 15th to 30th Nov 2021, while the In-Person event is being held between 24th to 26th Nov 2021 at India Expo Centre– Greater Noida, Delhi. In a bid to stay afloat towards increasing contemporary demand towards high qu...

Read More
news image

Business Insights

TASLY PHARMACEUTICALS AND MAUNA KEA TECHNOLOGIES ANNOUNCE JOINT VENTURE AND LICENSING AGREEMENTS

Mauna Kea Technologies | July 12, 2022

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, and Tasly Pharmaceuticals announced the execution of an agreement to form a Joint Venture. Under terms of the agreement, Tasly and Mauna Kea will form a Joint Venture that will (i) commercialize selected Cellvizio indications in China, (ii) develop and commercialize Cellvizio globally in the fields of Neurology and Neurosurgery, and (iii) manufact...

Read More
news image

Business Insights

OPTIMIZERX ACQUIRES EVINCEMED, A SPECIALTY DRUG PRESCRIPTION INITIATION PLATFORM

OptimizeRx Corporation | March 16, 2022

OptimizeRx Corp. a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a leader in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform supporting pharma manufacturers, hub providers and pharmacies to improve patient access, speed to therapy and activation of af...

Read More
news image

Business Insights, PHARMACY MARKET

VERISTAT ACQUIRES EUROPEAN MEDICAL WRITING CONSULTANCY SCINOPSIS

Businesswire | June 13, 2023

Veristat, a scientific-minded global clinical research organization (CRO), has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory and medical communication documents of the highest quality to the biopharmaceutical industry. The acquisition strengthens Veristat’s ability to meet growing client demand in one of its highest-valued service areas as the range of clinical trial content expands and the importance of regulatory doc...

Read More
news image

Pharma Tech

CPHI PARTNERS WITH INFORMA PHARMA INTELLIGENCE TO PRESENT THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO IN THE NATIONAL CAPITAL REGION ( NCR)

Informa Pharma Intelligence | November 26, 2021

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, is pleased to announce the 2021 hybrid edition of CPhI – P-MEC conducted by CPhI Conference. The Online Conference & Networking is being held between 15th to 30th Nov 2021, while the In-Person event is being held between 24th to 26th Nov 2021 at India Expo Centre– Greater Noida, Delhi. In a bid to stay afloat towards increasing contemporary demand towards high qu...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us